ON A MISSION TO GET BACK TO BUSINESS
Ogena and Puraclenz are companies working to solve the world’s biggest health crisis in over a century. To help solve this problem, we’ve assembled an experienced product development, production and sales team who share a vision and commitment to develop viable solutions for businesses and homes across the globe.
Our mission is to get people back to business and provide them with enhanced protection from the virus that causes COVID-19 and its viral offspring. We can do this using Puraclenz’s patented technology to safely clean indoor air and surfaces continuously* and efficiently.
Ogena and Puraclenz are working together on something that has never been done before: providing added* protection against dangerous viruses and bacteria, safely, effortlessly, and at a low cost, to help people everywhere live healthier and more productive lives.
PARTNERING WITH PURACLENZ
Having worked with the people at Puraclenz over the past two years, Ogena has developed much respect for Puraclenz’s highly ethical business approach.
We are also incredibly proud to say that Ogena has an agreement with Puraclenz that allows us to be the Exclusive Master Distributor of Puraclenz’s commercial grade systems into the Animal Health Market in North America, and to be the Exclusive Master Distributor to all commercial markets in Canada.
Ogena will sell the Puraclenz systems under the OgenaShield umbrella of products, in keeping with our commitment to bring the latest and most efficacious products into the marketplaces we serve (as we did with the introduction and dramatic success of Virox Technologies Accelerated Hydrogen Peroxide Disinfectants into the animal health market).
We can say without question that the Puraclenz-developed products are a true game-changer in the world of biosecurity. When there is a need to control viruses and bacteria both in the air and on surfaces Puraclenz products offer a dramatic enhancement to traditional cleaning and disinfecting practices.
*Independently-conducted efficacy tests confirm, in typical indoor settings, that a Puraclenz P3000 unit is proven to be 98.85% effective in reducing the MS2 Bacteriophage (MS2) virus in the air. MS2 is an approved surrogate (proxy) virus of SARS-CoV-2, the virus that causes COVID-19 due to the fact that is far more difficult to kill than all coronoviruses (including SARS-Cov-2, influenza, etc). The efficacy tests were performed by Aerosol Research and Engineering Laboratories in Olathe, Kansas, an FDA compliant laboratory.
In addition testing at Microbac Laboratories (also an FDA approved lab) has shown that the P3000 unit was able to kill over 60% of the virus that causes Covid-19 on surfaces (SARS-Cov-2), something that HEPA and other traditional filtering systems simply cannot do.
HISTORY OF THE PURACLENZ TECHNOLOGY
Puraclenz’s next-gen indoor purification technology started more than 10 years ago when a friend of one of their founders lost his life due to a Hospital Acquired Infection (HAI) and related malpractice. This event inspired a research dive into the growing problem of HAIs and the mounting death toll of over 100,000 annual US hospital patients and an estimated 1 million deaths globally.
The need for a low-priced, safe, and powerful solution became the mandate for the founders of Puraclenz. Further research led to a small company in Denver, Colorado (UVAIRx, Inc.) that had new ideas for improving the power and safety of the well-documented and proven photocatalytic oxidation (PCO) technology: the same technology used by NASA in the International Space Station (ISS) to provide healthier air for astronauts. Puraclenz’ founders provided UVAIRx, Inc with a substantial investment, as well as technical and management assistance. UVAIRx, Inc spent seven years developing and market-testing a new proprietary technology, for which they later received a US Patent. Under an Asset Purchase Agreement, Puraclenz acquired this patent and hired its inventor, Jerrod Keith, as VP of R&D. Puraclenz continued to add additional proprietary features to the patent and commenced the commercial development and production of this next-generation version of PCO technology.
The Puraclenz management team (Wendell Minnick, Chris Dooley and Jerrod Keith) have nearly three decades of experience developing and bringing to market consumer and industrial products applying advanced materials and proprietary designs. The team has an extensive history of leading proprietary industrial and consumer product development with such partners as DuPont, Lockheed, Corning, iRobot and Kodak, as well as inventing and producing numerous proprietary consumer products protected by global patents.
Puraclenz’ re-invention of interior air purification is well-timed to provide a powerful, low-cost and safe solution to help business and families combat the current global pandemic and any future viral-based threats.
MORE THAN JUST AN AIR PURIFIER
ACTIVE CLEANING TECHNOLOGY
Puraclenz’s next-gen ionization technology proactively cleans the air and surfaces in your environment.
ACTIVELY PURIFIES AIR AND SURFACES.
Using air as a medium to deliver ions allows the Puraclenz system to clean the air, including respiratory droplets and hard-to-reach surfaces missed by hand-cleaning or HEPA filters. This active process is scientifically proven by lab studies conducted with our products.
TRADITIONAL PASSIVE AIR PURIFICATION VS. THE PURACLENZ SYSTEM
When someone coughs or sneezes in a room being treated with passive air purifiers, such as HEPA filters, any pathogens (such as the virus that causes COVID-19) must move through the space back to the fan unit where it is captured by a filter.
While this approach is* effective, HEPA and other filtering systems must be sized and placed appropriately in order to be effective. With portable units, a separate unit is almost always required for each room. In contrast, the ions generated by the Puraclenz system are designed to deactivate pathogens efficiently before reaching other people in the room and a single unit can cover multiple rooms and up to 3,000 sq ft.
*Properly sized and placed HEPA systems have been shown to drop pathogenic loads in an indoor space by approximately 50% over a one hour period.
The underlying photocatalytic oxidation (PCO) technology (now advanced by Puraclenz) has been used successfully by doctors, dentists, nursery schools, fitness centers and millions of consumers around the world.
Traditional PCO technology has one negative aspect: it often utilizes ozone to increase its power to kill pathogens. Ozone is not a healthy addition to any indoor space, which is why the FDA limits ozone-producing products to .05ppm. Puraclenz has advanced and achieved patent protection for its new design because they found a way to generate powerful levels of ions without generating any ozone.
Using air as a medium to deliver ions allows the system to clean every exposed surface the air reaches, including hard to reach areas where contaminants may be found.
A single P3000 unit will purify multiples of rooms and spaces of up to 3,000 square feet. With multiple units, the coverage area is virtually limitless. See our FAQ (coming soon) and Competitive Product Compairson Chart for more information about optimizing coverage.
EFFECTIVE AGAINST VIRUSES
The technology used by Puraclenz has been proven to destroy the very difficult to kill MS2 Bacteriophage virus that is classified as a surrogate to SARS-CoV-2, the actual SARS-CoV-2 virus on surfaces, as well as all enveloped viruses such as H1N1 and H5N1, the viruses that cause influenza. According to EPA and CDC guidelines, Puraclenz technology is considered effective at neutralizing/killing SARS-CoV-2 and any of its mutated variants in the air and on surfaces. This includes other viruses that MS2 Bacteriophage is a surrogate (proxy) for such as influenza and the common cold.
SAFER FOR YOUR WORKPLACE
Unlike earlier generations of PCO purifiers, the Puraclenz system does not create ozone of any kind. It’s safe to use continuously around people, animals, and in environments such as restaurants, gyms, offices, lunchrooms and schools. In fact, our systems have achieved the following strict safety related testing standards:
- CARB (California Air Resource Board) approval. CARB is widely accepted as the “gold standard” in the world for measuring indoor air quality.
- UL2998 – Underwriter Lab’s new Certification standard created to highlight ozone free products.
Puraclenz is arguably one of the lowest (if not the lowest) installed cost per square foot of coverage of any comparable product on the market. See the comparison table below. Plus, it works automatically, requiring no added labour, equipment, or supplies.
OUR SYSTEM - PROVEN EFFECTIVENESS
Independently-conducted efficacy tests confirm Puraclenz is effective against all classes of viruses and bacteria.
Summary of independent clinical tests validating the effectiveness of PCO technology to deactivate a variety of pathogens:
- Virucidal Efficacy on Aerosols
- Virucidal Efficacy During “Sneeze” Test
- Efficacy On Surfaces
- Efficacy to Inactivate SARS-CoV-2 on Surfaces
- Efficacy to Inactivate Staphylococcus epidermidis
- VOC’s Challenge Gas Testing and Byproduct Analysis
- Efficacy to Inactivate Aspergillus brasiliensis (mold spore)
- All Lab Results
- Puraclenz Products Validating our Patented Advancement to PCO Technology – Available on request
- Historical Studies Validating Traditional Ozone based PCO Technology – Available on request
- MS2 Review